Search

Your search keyword '"Montcuquet, A"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Montcuquet, A" Remove constraint Author: "Montcuquet, A" Topic female Remove constraint Topic: female
44 results on '"Montcuquet, A"'

Search Results

1. Determinants of therapeutic lag in multiple sclerosis

2. Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

3. Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study

4. Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

5. Electrochemical skin conductance values suggest frequent subclinical autonomic involvement in patients with AL amyloidosis

6. Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults

7. Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders

8. Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France

9. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies

10. Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

11. Nod2Deficiency Leads to a Specific and Transmissible Mucosa-associated Microbial Dysbiosis Which Is Independent of the Mucosal Barrier Defect

12. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

13. In the Era of Genomics, Should Tumor Size Be Reconsidered as a Criterion for Neoadjuvant Chemotherapy?

14. Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence

15. Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: Impact of institutions

16. Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma

17. Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis

18. [Prevalence and management of pain in patients with metastatic cancer in Franche-Comté]

19. Validation of the French version of the colorectal-specific quality-of-life questionnaires EORTC QLQ-CR38 and FACT-C

20. Epirubicin–vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial

21. Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

22. Long-Term Cardiac Follow-Up in Relapse-Free Patients After Six Courses of Fluorouracil, Epirubicin, and Cyclophosphamide, With Either 50 or 100 mg of Epirubicin, As Adjuvant Therapy for Node-Positive Breast Cancer: French Adjuvant Study Group

23. [Efficacy, safety and cost of eribulin in patients with metastatic breast cancer]

24. First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimization analysis

25. Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?

26. In vivo fluorescence spectra unmixing and autofluorescence removal by sparse nonnegative matrix factorization

27. Nonnegative matrix factorization: a blind spectra separation method for in vivo fluorescent optical imaging

28. Sequential taxane and anthracycline-containing neoadjuvant regimens: the sequential order impact

29. Transcriptome of retrovirally transduced CD8+ lymphocytes: influence of cell activation, transgene integration, and selection process

30. Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma

31. Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

32. [Influence of the delay between conservative surgery and radiation therapy on local relapse in node-positive breast tumor]

33. Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group

34. Digital necrosis and lupus-like syndrome preceding ovarian carcinoma

35. Large Granular Lymphocytic Leukemia: A Treatable Form of Refractory Celiac Disease

36. Improved bioavailability of a new oral preparation of medroxyprogesterone acetate

37. Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study Group

38. Phase II study of epirubicin in advanced soft tissue sarcoma

39. Autologous bone marrow transplantation (ABMT) for acute leukaemia in complete remission: a pilot study of 33 cases

40. Marrow transplantation from HLA non-identical family donors for the treatment of leukaemia: a pilot study of 15 patients using additional immunosuppression and T-cell depletion

41. Delay from treatment start to full effect of immunotherapies for multiple sclerosis

42. Bronchial carcinoma after cervical carcinoma

43. [Denny-Brown sensory neuropathy disclosing a bilateral ovarian adenocarcinoma]

44. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

Catalog

Books, media, physical & digital resources